Idience Co., Ltd.
PrivateLast Round
Strategic
May 20, 2024
Total Funding Raised
$66M
Company Overview
Idience Co., Ltd. is a biopharmaceutical company that develops targeted oncology therapies, including its lead PARP inhibitor candidate, Venadaparib.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Idience Co., Ltd. Comparables
Compare Idience Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Duke Street Bio | 87% | |
| Onconic Therapeutics | 81% | |
| Synnovation Therapeutics | 81% |
Idience Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 20, 2024 | ||||
| Series B | Jul 1, 2022 | ||||
| Series A | Nov 9, 2020 |
Idience Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seoul Investment Partners | Series B, Series A |
| KIWOOM Securities Co., Ltd. | Series B |
| TS Investment | Series A |
| Ildong Holdings Co., Ltd. | Series B |
| Mirae Asset Capital | Series A |
| Yuanta Investment | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 28, 2024
Monthly visitors increased 84% MoM, reaching 1.8K.
- Jul 1, 2022
$12M round with participation from Ildong Holdings and KIWOOM Securities.
Idience Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Idience Co., Ltd.'s valuation, stock price, and market status.
Is Idience Co., Ltd. a public or private company?
Idience Co., Ltd. is a private company.
What is the current stock price of Idience Co., Ltd.?
Idience Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Idience Co., Ltd. worth (valuation)?
Valuation information for Idience Co., Ltd. is not publicly available.
Can I buy Idience Co., Ltd. stock?
Idience Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Idience Co., Ltd.'s last funding round?
Idience Co., Ltd.'s most recent funding round was Strategic on May 20, 2024.
Who are the main investors in Idience Co., Ltd.?
Key investors in Idience Co., Ltd. include Seoul Investment Partners, KIWOOM Securities Co., Ltd., TS Investment, Ildong Holdings Co., Ltd., Mirae Asset Capital.
Will Idience Co., Ltd. IPO soon?
No public IPO plans have been announced for Idience Co., Ltd..
How can I track Idience Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Idience Co., Ltd.'s secondary market activity and sign up for updates.